ALX ONCOLOGY HOLDINGS INC Balance Sheet
ALXO|3 years of annual SEC 10-K data (FY2020-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
ALX ONCOLOGY HOLDINGS INC had $306M in total assets and $263M in shareholders' equity as of FY2022. Total debt was $11M against $49M in cash, resulting in a $38M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Cash & Equivalents | $48.8M | $434.2M | $434.2M |
| Current Assets | $271.0M | $367.0M | $436.0M |
| PP&E (Net) | $3.9M | $897.0K | $52.0K |
| Total Assets | $306.5M | $380.2M | $436.1M |
| Current Liabilities | $28.3M | $15.3M | $6.2M |
| Total Debt | $10.6M | - | - |
| Shareholders' Equity | $263.5M | -$70.6M | -$51.8M |